RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Antibiotic susceptibilities of bacteria isolated from acute dentoalveolar abscesses.

The antibiotic susceptibilities of 166 bacterial strains (43 facultative anaerobes and 123 strict anaerobes) cultured from 50 acute dentoalveolar abscesses was assessed. Firstly, the effectiveness of five antibiotics, penicillin, amoxycillin, erythromycin, clindamycin and metronidazole, which are available to treat acute dental infection, was studied using a Stokes' comparative disc diffusion method. Secondly, the minimum inhibitory concentrations and minimum bactericidal concentrations were determined for isolates of the predominant species, especially those strains deemed resistant by the Stokes' method. It was concluded that the vast majority of bacterial strains (96%) were sensitive or moderately sensitive to the antibiotics tested. However, resistance was recorded for each of the antibiotics tested on at least one occasion. The MIC of penicillin, presently the drug of choice for acute dental infection, was between 0.03 and 2 mg/l for the majority of strains (96%).

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app